Trump to announce $750 million deal with Abbott for at least 150 million rapid coronavirus tests

Health, Fitness & Food

A sign displays a new rapid coronavirus test on the new Abbott ID Now machine at a ProHEALTH center in Brooklyn on August 27, 2020 in New York City. The portable Abbott ID Now uses a nasal swab to detect acute and infectious cases of COVID-19. ProHEALTH is offering the new service, which can deliver a test result in a s little as 15 minutes, at its centers in the tri-state area.

Spencer Platt | Getty Images

President Donald Trump plans to announce Thursday the purchase of 150 million rapid Covid-19 tests as part of a $750 million agreement with Abbott Laboratories, a White House official confirmed to NBC News. 

Trump plans to use his speech at the Republican National Convention to announce the deal, the official said.

“Under President Trump’s leadership, the U.S. is leading the world in testing,” White House communications director Alyssa Farah said in a statement to NBC News. “This is a major development that will help our country to remain open, get Americans back to work, and kids back to school. The Trump Administration is proud to partner with Abbott labs to make this purchase possible to help the American people.”

 The Food and Drug Administration granted emergency use approval late Wednesday to Abbott for its new coronavirus antigen test, which is the first Covid-19 test that it says costs about $5 and delivers results in minutes on a testing card without lab equipment, similar to a pregnancy test. 

Shares of Abbott were up more than 9% in intraday trading Thursday.

Representatives of the White House and Abbott Labs did not immediately return CNBC’s request for comment.

This is breaking news. Check back here for updates.

Products You May Like

Articles You May Like

Coronavirus live updates: Struggling restaurants brace for winter; WHO reports record one-day spike in cases
Europe on high alert as coronavirus cases rise and targeted lockdowns return
Public health specialists criticize Trump administration over reports it interfered with CDC studies
Scientists question ‘strange’ data in Russian coronavirus vaccine trial after ‘unlikely’ patterns
Coronavirus updates: Fauci concerned about current U.S. trends; universities become the latest hotspots

Leave a Reply

Your email address will not be published. Required fields are marked *